The trademark application IMMUNITAS was filed by Immunitas Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 31, 2020, and it was registered by office on December 9, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders.
The mark was filed in class 42 with Pharmaceutical research and development.